Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.480
+0.040 (1.16%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $214.43 million as of August 25, 2026. Its market cap has increased by 12.68% in one year.
Market Cap
214.43M
Enterprise Value
98.18M
1-Year Change
12.68%
Ranking
Category
Stock Price
$3.48
ChartMarket Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $214.43M, a decrease of -53.04%. That is a compound annual growth rate of -6.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 214.40M | -1.88% |
| Dec 31, 2025 | 218.50M | -29.45% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunic | 225.00M |
| NervGen Pharma | 221.50M |
| Acumen Pharmaceuticals | 220.21M |
| Corbus Pharmaceuticals Holdings | 215.66M |
| AN2 Therapeutics | 213.59M |
| Oramed Pharmaceuticals | 210.90M |
| Coherus Oncology | 209.35M |
| Alpha Cognition | 209.07M |